Guangdong, China

Zhe Fang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhe Fang: Innovator in Antitumor Polysaccharide Compounds

Introduction

Zhe Fang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of plant extraction and separation technology. His innovative work focuses on developing compounds that can enhance the efficacy of cancer treatments.

Latest Patents

Zhe Fang holds a patent for a polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugs. This invention is particularly relevant for advanced cancer patients who are not candidates for surgery and have limited life expectancy. The molecular formula of the compound is (CHO). The active ingredient is derived from effective components extracted under high temperature and high pressure. This polysaccharide is characterized by its water solubility, allowing for easy absorption by the human body. It offers antitumor effects and has demonstrated efficacy in preventing tumor development in humans.

Career Highlights

Zhe Fang is associated with Shenzhen Yandai Investment Co., Ltd., where he continues to innovate in the field of cancer treatment. His work is pivotal in providing alternative solutions for patients facing severe health challenges due to cancer.

Collaborations

Zhe Fang has collaborated with notable colleagues, including Xuemin Chen and Chunming He, to advance research and development in his field.

Conclusion

Zhe Fang's contributions to the development of antitumor polysaccharide compounds represent a significant advancement in cancer treatment. His innovative approach offers hope for patients with limited options, showcasing the potential of plant-based solutions in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…